REMS Assessment: Planning and Reporting
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 1, 2019
April 17, 2020
c1fedc97-921d-4bcf-8c8f-2ea35b441b95
Related Documents
Child-Resistant Packaging Statements in Drug Product Labeling Guidance for Industry
Guidance DocumentAugust 13, 2019Center for Drug Evaluation and Research
Immunogenicity Testing of Therapeutic Protein Products —Developing and Validating Assays for Anti-Drug Antibody Detection
Guidance DocumentFebruary 1, 2019Center for Drug Evaluation and Research
Format and Content of a REMS Document Guidance for Industry
Guidance DocumentJanuary 4, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.